잠시만 기다려 주세요. 로딩중입니다.

抑癌性血淸 Beta-lipoprotein의 臨床的 硏究(豫報)

Clinical Study of cancer Inhibiling Human Serum β-lipoprotein (Priliminary Report)

대한외과학회지 1970년 12권 3호 p.27 ~ 30
진병호,
소속 상세정보
진병호 (  ) - 서울대학교 의과대학 외과학교실 암연구소

Abstract


In the studies of tissue growth, Some workers suggested lipoprotein to be a inhibiting factor.
We also studied tissue growth inhibiting factors in various tissues, observed those factors to be similar to beta-lipoprotein.
From human serum, beta-lipoprotein is isolated by modified Burstein´s method, and animal researchs about normal and malignant tissues are conducted with above mentioned β-lipoproteine, Results obtained were as follow and as expected.
From this evidence, we conducted a trial of clinical treatment on 2 cases (1 squamous cell cancer on skin and 1 adenocarcinoma in rectum) with certain doses of β-lipoprotein around 30 days every day. as a result, ensuing necrosis, softening and finally regression of cancer tissues were observed and no siginficant complications were noted.
These studies are now progressing and final result are pending.

키워드

원문 및 링크아웃 정보

 

등재저널 정보

KCI
KoreaMed
KAMS